Richmond Pharmacology is pleased to confirm our attendance at the EASL Congress 2025 in Amsterdam, one of the leading global events dedicated to liver research and hepatology, hosted by the European Association for the Study of the Liver.
This year’s congress will bring together experts from across the world to share the latest developments in liver disease research, clinical innovation, and therapeutic advances.
Representing Richmond Pharmacology:
Our team looks forward to engaging with clinical leaders, researchers, and industry partners to explore opportunities in:
If you are attending EASL Congress and would like to learn how Richmond Pharmacology can support your liver-focused clinical development, we welcome you to connect with us during the event.
For meeting requests or collaboration enquiries:
info@richmondpharmacology.com
Learn more about the event:
.svg){kind=small}
-min.jpg)
.jpg)
